The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

Meeting Reports

  • CDDF 11th Spring Conference 2020 – read the report
  • CDDF Multi-stakeholder workshop on the Use of Real-World Data to Optimize Oncology Drug Development and Access, November 2019 – read the report
  • CDDF Multi-stakeholder workshop on Involving Patients In Oncology Drug Development, June 2019- read the report
  • CDDF Multi-stakeholder workshop on Impact of the Microbiome on Cancer Growth and Therapy – read the report
  • CDDF Multi-stakeholder workshop on Minimal Residual Disease in AML – CLL, Nov 2018 – read the report
  • CDDF Multi-stakeholder workshop on Biomarkers and Patients’ Access to Personalized Oncology Drugs in Europe, 2018 – read the report
  • CDDF 10th Alpine Conference on Current and Future Challenges of Innovative Oncology Drugs Development, 2018 – read the report
  • CDDF Multi-stakeholder workshop on Minimal Residual Disease, 2017 – read the report
  • CDDF-ENCA-ITCC-SIOPE 3rd Paediatric Oncology Conference, 2015 – read the report
  • 8th CDDF Alpine Conference, 2015 – read the report
  • ITOC-2, 2015 – read the report

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752

info@cddf.org
Tel: +32 2 880 62 70